Viking Therapeutics (VKTX) Treasury Shares (2022 - 2023)

Viking Therapeutics has reported Treasury Shares for 13 years, with the latest figure at $1.8 million in Q2 2026.

• Quarterly Treasury Shares changed 0.0% year-over-year to $6.8 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $6.8 million (changed 0.0% YoY) and the FY2023 annual result came in at $6.8 million, changed 0.0% from the prior year.
• Treasury Shares steadied at $6.8 million in Q4 2023 per VKTX's latest filing, from $6.8 million in the prior quarter.
• Over five years, Treasury Shares peaked at $6.8 million in Q3 2022 and troughed at $1.7 million in Q2 2022.
• A 5-year average of $2.4 million and a median of $2.3 million in 2025 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2022 and 2026: Treasury Shares jumped 127.92% in 2022, then dropped 21.09% in 2026.
• Over 2 years, Treasury Shares stood at $6.8 million in 2022, then changed by 0.0% to $6.8 million in 2023.
• According to Business Quant data, Treasury Shares over the past three periods registered $6.8 million, $6.8 million, and $6.8 million for Q4 2023, Q3 2023, and Q2 2023 respectively.